FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Golden State Medical Supply Aripiprazole Tablets Recall

ARIPIPRAZOLE TABLETS, 15 mg, 30-count

Golden State Medical Supply Inc. · Camarillo, CA

Risk level
Class II
Reported by FDA
Dec 9, 2020
Recall ID
D-0112-2021
Check your lot numberHow we source this data

Summary

Golden State Medical Supply recalled Aripiprazole Tablets starting Nov 17, 2020. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0112-2021 on Dec 9, 2020. Reason: FAILED DISSOLUTION SPECIFICATIONS: Possibility of out-of-specification (OOS) dissolution limits for the remaining shelf life of the Aripiprazole Tablets. Status: Terminated.

Why it was recalled

FAILED DISSOLUTION SPECIFICATIONS: Possibility of out-of-specification (OOS) dissolution limits for the remaining shelf life of the Aripiprazole Tablets

Product description

ARIPIPRAZOLE TABLETS, 15 mg, 30-count. bottles, Rx Only, GSMS Incorporated, Manufactured by: Apotex Inc. Toronto, Ontario, Canada, Packaged by GSMS, Incorporated, Camarillo, CA 93012 USA, NDC #60429-449-30

Lot numbers, UPCs & expiration codes

Lot #: GS026353, GS027150, GS027653, GS028044, Exp. Date: 02/2021

Where it was sold

Distributed Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0112-2021
Classification
Class II
Status
Terminated
Recall initiated
Nov 17, 2020
FDA report date
Dec 9, 2020
Quantity
11,922 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Golden State Medical Supply Inc.

Original FDA data

Every field from FDA enforcement report D-0112-2021, exactly as published.

Show all FDA fields
City
Camarillo
State
CA
Status
Terminated
Country
United States
Event ID
86786
Address
5187 Camino Ruiz
Code information
Lot #: GS026353, GS027150, GS027653, GS028044, Exp. Date: 02/2021
Postal code
93012-8601
Report date
Dec 9, 2020
Product type
Drugs
Recall number
D-0112-2021
Classification
Class II
Recalling firm
Golden State Medical Supply Inc.
Product quantity
11,922 bottles
Termination date
Jul 22, 2022
Reason for recall
FAILED DISSOLUTION SPECIFICATIONS: Possibility of out-of-specification (OOS) dissolution limits for the remaining shelf life of the Aripiprazole Tablets
Voluntary / mandated
Voluntary: Firm initiated
Product description
ARIPIPRAZOLE TABLETS, 15 mg, 30-count. bottles, Rx Only, GSMS Incorporated, Manufactured by: Apotex Inc. Toronto, Ontario, Canada, Packaged by GSMS, Incorporated, Camarillo, CA 93012 USA, NDC #60429-449-30
Distribution pattern
Distributed Nationwide in the USA
Recall initiation date
Nov 17, 2020
Initial firm notification
Letter
Center classification date
Nov 30, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0112-2021, published Dec 9, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls